Geode Capital Management, LLC Entera Bio Ltd. Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 21,136 shares of ENTX stock, worth $57,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,136
Previous 21,136 -0.0%
Holding current value
$57,278
Previous $40,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$1.54 - $2.26 $5,450 - $7,998
3,539 Added 20.11%
21,136 $43,000
Q2 2021

Aug 13, 2021
BUY
$2.92 - $6.5 $51,383 - $114,380
17,597 New
17,597 $105,000

Others Institutions Holding ENTX

# of Institutions
25
Shares Held
9.21M
Call Options Held
21.1K
Put Options Held
0
View Full List

About Entera Bio Ltd.

ENTX Quotes by TradingView
  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $78.1M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email